0000899243-21-024530.txt : 20210617
0000899243-21-024530.hdr.sgml : 20210617
20210617195502
ACCESSION NUMBER: 0000899243-21-024530
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210615
FILED AS OF DATE: 20210617
DATE AS OF CHANGE: 20210617
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ambros Reinhard J.
CENTRAL INDEX KEY: 0001709690
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38130
FILM NUMBER: 211026634
MAIL ADDRESS:
STREET 1: C/O AILERON THERAPEUTICS, INC.
STREET 2: 281 ALBANY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AILERON THERAPEUTICS INC
CENTRAL INDEX KEY: 0001420565
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 285 SUMMER STREET
STREET 2: UNIT 101
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 617-995-0900
MAIL ADDRESS:
STREET 1: 285 SUMMER STREET
STREET 2: UNIT 101
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-06-15
0
0001420565
AILERON THERAPEUTICS INC
ALRN
0001709690
Ambros Reinhard J.
C/O AILERON THERAPEUTICS, INC.
285 SUMMER STREET, SUITE 101
BOSTON
MA
02210
1
0
0
0
Stock Option (right to buy)
1.29
2021-06-15
4
A
0
96000
0.00
A
2031-06-14
Common Stock
96000
96000
D
This option was granted on June 15, 2021. The shares underlying the option are scheduled to vest in full on the earlier of (i) June 15, 2022 or (ii) the date of the Issuer's 2022 Annual Meeting of Stockholders.
/s/ Richard Wanstall, attorney-in-fact for Reinhard J. Ambros
2021-06-17